Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-22

Clinical Trial Update: Blocking Mifepristone Action With Progesterone [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial studying blocking mifepristone action with progesterone in unwanted pregnancy was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mifepristone (mifepristone)
  • PROGESTERONE (Progesterone)

Snippet

Sponsor: University of California, Davis | Conditions: Pregnancy, Unwanted | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2020-01-22